Recent steroid findings in "designer supplements"
Deutscher übersetzter Titel: | Neueste Steroidfunde in Designer Supplementen |
---|---|
Autor: | Parr, M.K.; Haenelt, N.; Fußhöller, G.; Flenker, U.; Geyer, Hans; Rodchenkov, Grigory M.; Opfermann, G.; Schänzer, Wilhelm |
Erschienen in: | Recent advances in doping analysis (17) : Proceedings of the Manfred Donike Workshop ; 27th Cologne Workshop on Dope Analysis ; 1st to 6th March 2009 |
Veröffentlicht: | Köln: Sportverl. Strauß (Verlag), 2009, S. 71-80, Lit. |
Format: | Literatur (SPOLIT) |
Publikationstyp: | Sammelwerksbeitrag |
Medienart: | Gedruckte Ressource |
Sprache: | Englisch |
Schlagworte: | |
Online Zugang: | |
Erfassungsnummer: | PU201101000518 |
Quelle: | BISp |
Abstract
Several supplements have been purchased from two different internet-based suppliers and were analysed for their steroid content. Besides the findings of DHEA (and DHEA esters) products were found to contain 6-bromoandrostenedione, androstanoisoxazoles, and estra-4,9-diene-3,17-dione. Additionally ∆6-methyltestosterone was detected in the product "Jungle Warfare" from ALR Industries, androst-4-ene-3,11,17-trione in the product “11Oxo" from Ergopharm, and finally the product "Oxyguno" distributed by Spectra Force Research was found to contain 4-chloro-11-oxomethyltestosterone. These three compounds have been reported in the 1960s to show weak androgenic (about 1/2 of testosterone) and from weak to strong anabolic properties. The urinary metabolism was studied following the administration of one capsule to one test person each. The administration of ∆6-methyltestosterone was detectable for more than one week by monitoring the metabolites 17α-hydroxy-17ß-rnethylandrosta-4,6-dien-3-one, 17α-rnethyl-5ß-androstane-3α,17ß-diol, and 17ß-methyl-5ß-androstane-3α,17α-diol. Oral administration of androst-4-ene-3,11,17-trione resulted in several reduced metabolites with 11ß-hydroxyandrosterone as main product. Isotope ratio mass spectrometry confirmed the exogenous origin of 11ß-hydroxyandrosterone and 11ß-hydroxyetiocholanolone as well as their 11-oxo precursors for up to 24 hours. 4-Chloro-11ß-hydroxymethyltestosterone (4-chloro-11ß,17ß-dihydroxy-17α-methylandrost-4-en-3-one) was identified as main urinary metabolite following the ingestion of 4-chloro-11-oxomethyltestosterone. Verf.-Referat